Vancomycin and oxacillin synergy for methicillin-resistant staphylococci

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 5, 2000, Pages 1394-1396

  Domaracki, Beth E ^a   Evans, Ann M ^a   Venezia, Richard A ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXACILLIN; VANCOMYCIN;

ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; DRUG POTENTIATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS;

DRUG SYNERGISM; DRUG THERAPY, COMBINATION; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OXACILLIN; STAPHYLOCOCCUS; TIME FACTORS; VANCOMYCIN;

EID: 0034048698     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.5.1394-1396.2000     Document Type: Article

References (15)

1. Bajaksouzian, S., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1997. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies. Antimicrob. Agents Chemother. 41:1073-1076.
2. Biavasco, F., E. Giovanetti, M. P. Montanari, R. Lupidi, and P. E. Varaldo. 1991. In vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcus haemolyticus and Staphylococcus epidermidis. Eur. J. Clin. Microbiol. Infect. Dis. 27:71-79.
3. Centers for Disease Control and Prevention. 1997. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. Morbid. Mortal. Weekly Rep. 46:765-766.
4. Centers for Disease Control and Prevention. 1997. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1998. Morbid. Mortal. Weekly Rep. 46:813-815.
5. Domaracki, B. E., A. Evans, K. E. Preston, H. Fraimow, and R. A. Venezia. 1998. Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 17:143-150.
6. Herwaldt, L., L. Boyken, and M. Pfaller. 1991. In vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcus haemolyticus and Staphylococcus epidermidis. Eur. J. Clin. Microbiol. Infect. Dis. 10:1007-1012.
7. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-146.
8. National Committee for Clinical Laboratory Standards. 1996. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. Schwalbe, R. S., J. T. Stapelton, and P. H. Gilligan. 1987. Emergence of vancomycin resistance in coagulase-negative staphylococci. N. Engl. J. Med. 316:927-931.
10. Schwalbe, R. S., W. J. Ritz, P. R. Verma, E. A. Barranco, and P. H. Gilligan. 1990. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J. Infect. Dis. 161:45-51.
11. Seibert, G., D. Isert, N. Kiesel, M. Limbert, A. Markus, and E. Schrinner. 1992. The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus. J. Antimicrob. Chemother. 29(Suppl. A):25-30.
12. Sieradzki, K., and A. Tomasz. 1997. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aurais. J. Bacteriol. 179:2557-2566.
13. Sieradzki, K., P. Villari, and A. Tomasz. 1998. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 42:100-107.
14. Sieradzki, K., P. R. B. Roberts, S. W. Haber, and A. Tomasz. 1999. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340:517-523.
15. Smith, T. L., M. L. Pearson, K. R. Wilcox, C. Cruz, M. V. Lancaster, B. Robinson-Dunn, F. C. Tenover, M. J. Zervos, J. D. Band, E. White, and W. R. Jarvis for the Glycopeptide-Intermediate Staphylococcus aureus Working Group. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. N. Engl. J. Med. 340:493-501.